Nov 21, 2023 · Xtandi is an androgen receptor inhibitor used to treat certain prostate cancers. Xtandi works by preventing the actions of androgens (male hormones), to help control cancer …

Información relativa al paciente del fármaco Xtandi revisada por un médico - incluye descripción, efectos secundarios (o reacciones adversas), posología e instrucciones de uso.

Apr 3, 2023 · Xtandi should not be given at the same time as strong CYP2C8 inducers, such as rifampicin, secobarbital, phenobarbital, or phenytoin. If coadministration is unavoidable, …

Nov 22, 2023 · Xtandi comes in the form of a capsule or a tablet, which is taken once a day alongside a gonadotropin-releasing hormone (GnRH) analog or bilateral orchiectomy. Xtandi is …

Nov 21, 2023 · Xtandi is an androgen receptor inhibitor or anti-androgen. Androgens are a group of hormones, which includes testosterone, that stimulate prostate cancer cells to grow. Xtandi …

Xtandi Interactions. There are 676 drugs known to interact with Xtandi (enzalutamide), along with 2 disease interactions. Of the total drug interactions, 248 are major, 415 are moderate, and 13 …

Mar 18, 2025 · For patients who receive XTANDI with or without a GnRH analog, treatment can be suspended if PSA is undetectable (< 0.2 ng/mL) after 36 weeks of therapy. Reinitiate …

Sep 16, 2013 · XTANDI is a strong CYP3A4 inducer and a moderate CYP2C9 and CYP2C19 inducer. The coadministration of XTANDI decreases the concentrations of certain CYP3A4, …

Xtandi Coupons, Copay Cards and Rebates. Xtandi offers may take the form of printable coupons, rebates, savings or copay cards, trial offers, or free samples. Certain offers may be …

May 5, 2025 · Note: This document provides detailed information about Xtandi. Applies to enzalutamide: oral capsule liquid filled, oral tablet Side Effects associated with enzalutamide. …